Concepedia

Publication | Closed Access

Gemcitabine plus oxaliplatin (GEMOX) in patients with advanced hepatocellular carcinoma (HCC)

DOI

191

Citations

43

References

2007

Year

Samy Louafi, Valérie Boige, Michel Ducreux, Luminita Bonyhay, Touraj Mansourbakht, Thierry de Baère, Amani Asnacios, L Hannoun, Thierry Poynard
Cancer

Abstract

The GEMOX regimen seems to be well tolerated and active in advanced HCC, especially in patients with underlying nonalcoholic liver disease. A Phase II study of the GEMOX regimen plus cetuximab is ongoing.

References

YearCitations

Page 1